Articles tagged with “cancer-drug-development”

Pfizer-Innovent $10.5B Deal & China Licensing Playbook

Examine the $10.5B Pfizer-Innovent collaboration. This analysis covers their 12-drug ADC oncology portfolio and the China cross-border licensing playbook.

35 min read

5/13/2026

pfizer innovent deal oncology licensing antibody drug conjugates cross-border licensing cancer drug development multispecific antibodies pharma partnerships china biotech